Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Cellular senescence
Research brief

Mouse study: radiation-induced atrial fibrillation linked to cellular senescence via GATA4-NF-κB

In irradiated mice, DNA damage and cellular senescence via the GATA4-NF-κB pathway accompanied atrial remodeling and greater susceptibility to atrial fibrillation; the senolytic combination dasatinib and quercetin reduced these changes in the abstract. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Irradiated mice showed dose-dependent atrial structural and electrophysiological remodeling. [1]

  2. In irradiated HL-1 atrial cardiomyocytes, GATA4 knockdown suppressed cellular senescence and SASP expression. [1]

  3. In irradiated mice, dasatinib plus quercetin reduced susceptibility to atrial fibrillation. [1]

The source at a glance

Study type / format
Preclinical animal and cell study (abstract)
Population / context
Mice with locally irradiated hearts and irradiated HL-1 atrial cardiomyocytes
Summary based on
Study abstract
Original publication
September 15, 2026

Irradiated mice and atrial cardiomyocytes in the study

The abstract describes an in vivo mouse model in which the heart was locally irradiated with 20 Gy X-rays, plus in vitro work with irradiated HL-1 atrial cardiomyocytes. The stated aim was to clarify the role of cellular senescence and the GATA4-NF-κB signaling pathway in radiation-induced atrial remodeling and atrial fibrillation. Irradiated mice showed dose-dependent structural and electrophysiological remodeling of the atria.

Supporting source [1]

Senescence markers and GATA4 knockdown in the abstract

Transcriptomic analysis showed enrichment in DNA damage response, NF-κB signaling and aging-related pathways. Radiation induced DNA damage, activated ATM/ATR pathways and enhanced autophagic flux, leading to GATA4 accumulation and NF-κB phosphorylation, which drove senescence-associated secretory phenotype expression alongside increased SA-β-gal activity. In irradiated HL-1 cells, GATA4 knockdown suppressed cellular senescence and SASP expression.

Supporting source [1]

Dasatinib plus quercetin reduced atrial changes in mice

In irradiated mice, treatment with the senolytic combination dasatinib and quercetin (D/Q) alleviated DNA damage, inhibited excessive autophagy and suppressed the GATA4-NF-κB pathway, lowering SASP levels. These improvements reversed atrial structural and electrophysiological remodeling and markedly reduced susceptibility to atrial fibrillation. The abstract frames D/Q as a promising strategy for preventing radiation-induced atrial fibrillation; this is a preclinical finding, not evidence of benefit in people.

Supporting source [1]

How to interpret this

This is an abstract; the full text was not reviewed. Findings come from a mouse model and HL-1 atrial cardiomyocytes, so they are preclinical and do not establish benefit or safety in people. The abstract does not report sample sizes, follow-up or detailed statistics.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Radiation-induced atrial fibrillation is driven by cellular senescence via the GATA4 - NF-κB pathway and rescued by D/Q senolytic therapy.

Zhang C, Lan H, Yu L, Zhao J, Huang T, Sun B, Meng S, Duan J, Liu J, Zhou Z, Wang Z, Li J, Huang X, Wang H. · europepmc.org · September 15, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    dose-dependent atrial structural and electrophysiological remodeling
  2. Finding 2 ↑

    knockdown of GATA4 effectively suppressed both cellular
  3. Finding 3 ↑

    reduced susceptibility to AF

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…